Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

02/28/04 State Unveils Childhood Cancer License Plate        

02/28/04 The UCLA Neuro-Oncology Program is having its Fourth Annual Brain Tumor Conference on March 26-27, 2004        

02/23/04 Cognitive deficits in adult patients with brain tumours        

02/23/04 Gamma rays rid boy of tumor        

02/23/04 Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy.        

02/23/04 A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease.        

02/23/04 Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma.        

02/23/04 When Lung Cancer Spreads        

02/22/04 Age-related differences in 1p and 19q deletions in oligodendrogliomas        

02/22/04 URGENT PRODUCT RECALL
JANSSEN PHARMACEUTICA ANNOUNCES RECALL OF ONE LOT (CONTROL NUMBER 0327192) OF 75 MCG/HOUR DURAGESIC® (FENTANYL TRANSDERMAL SYSTEM CII) PATCHES        

02/21/04 Monteris Medical Inc. to Present at Medtech Insight's Investment In Innovation Conference        

02/21/04 OpGen's Collaboration With Henry Ford Hospital's Hermelin Brain Tumor Center Will Enable Researchers To Determine Effectiveness of Drug Therapies For Patients        

02/21/04 Presentation and outcome of 93 cases of craniopharyngioma        

02/17/04 Tamoxifen blocks vascular endothelial growth factor in breast cancer tumors.        

02/17/04 VEGF is the driving force behind neurogenesis and angiogenesis linkage.        

02/17/04 Moms tracking brain tumors        

02/17/04 Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.        

02/17/04 High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.        

02/17/04 Brain Scans Used to Monitor Effect of Cancer Drug        

---

Displaying Stories 5361 to 5380 of 7668
Previous 20           Next 20